Melvin K. Spigelman - Jun 19, 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Joshua Eizen, Attorney-in-Fact for Melvin K. Spigelman
Stock symbol
ANTX
Transactions as of
Jun 19, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 05:58 PM
Previous filing
Jun 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest on the earlier of (a) the one-year anniversary of June 19, 2024 or (b) the day prior to the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person providing continuous service through such vesting date.

Remarks:

Exhibits: Power of Attorney